Curetis

About:

Curetis is a molecular diagnostic firm focused on the development and commercialization of tools for diagnosing severe infectious diseases.

Website: http://www.curetis.com

Twitter/X: curetisusa

Top Investors: KfW, European Investment Bank, Yorkville Advisors, Forbion Capital Partners, EQT Life Sciences

Description:

Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases. Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.